Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Shunsuke Okazaki"'
Autor:
Fumihiro Kashizaki, Kenji Konishi, Chihiro Yamada, Shunsuke Okazaki, Hao Chen, Atsushi Miyasaka, Nanami Tsuchiya, Akitomo Kikuchi, Kentaro Yumoto, Yui Kojima, Hiroyuki Osawa, Harumi Koizumi, Kenichi Takahashi, Takeshi Kaneko
Publikováno v:
Respiratory Medicine Case Reports, Vol 48, Iss , Pp 102011- (2024)
Inflammatory endobronchial polyps (IEPs) are rare, benign bronchial tumors posing diagnostic and therapeutic challenges owing to limited data. A 55-year-old man, receiving treatment for allergic bronchopulmonary aspergillosis, presented with a one-we
Externí odkaz:
https://doaj.org/article/6572fe7a3b5648b681496ab28b4bb212
Publikováno v:
Life, Vol 11, Iss 8, p 796 (2021)
Next-generation sequencing-based comprehensive genome profiling (CGP) testing, OncoGuide NCC Oncopanel System, and FoundationOne CDx Cancer Genomic Profile have been covered by the Japanese national health insurance system since June 2019. Because CG
Externí odkaz:
https://doaj.org/article/0b6cbe686e4c43dc9520dfe384558f5b
Autor:
Koichi Taira, Shunsuke Okazaki, Kohei Akiyoshi, Hirohisa Machida, Tetsuro Ikeya, Akie Kimura, Akinobu Nakata, Yuji Nadatani, Masaki Ohminami, Shusei Fukunaga, Koji Otani, Shuhei Hosomi, Fumio Tanaka, Noriko Kamata, Yasuaki Nagami, Yasuhiro Fujiwara
Publikováno v:
Molecular and clinical oncology. 17(3)
Bevacizumab is a humanized monoclonal antibody that contains10% murine protein. To prevent infusion-related hypersensitivity reactions (HSRs), the initial bevacizumab infusion is delivered for 90 min, the second for 60 min and subsequent doses for 30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c743f25a31484123d19a2549992ca33
https://pubmed.ncbi.nlm.nih.gov/35949896
https://pubmed.ncbi.nlm.nih.gov/35949896
Publikováno v:
Life
Life, Vol 11, Iss 796, p 796 (2021)
Life, Vol 11, Iss 796, p 796 (2021)
Next-generation sequencing-based comprehensive genome profiling (CGP) testing, OncoGuide NCC Oncopanel System, and FoundationOne CDx Cancer Genomic Profile have been covered by the Japanese national health insurance system since June 2019. Because CG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc74d5d53cbcf600445f37ab08965731
https://pubmed.ncbi.nlm.nih.gov/34440540
https://pubmed.ncbi.nlm.nih.gov/34440540
Autor:
Shunsuke Okazaki, Masanori Fujita
Publikováno v:
AIJ Journal of Technology and Design. 24:1047-1051
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c62e77234f099c45e71d64c1eca277b
https://doi.org/10.3130/aijt.24.1047
https://doi.org/10.3130/aijt.24.1047
Autor:
Tetsuya Hamaguchi, Hidekazu Hirano, Masahiro Goto, Atsushi Naganuma, Satoru Iwasa, Shunsuke Okazaki, Ken Kato, Yoshitaka Honma, Yusuke Sasaki, Kengo Nagashima, Yushi Nagai, Atsuo Takashima, Yasushi Kojima
Publikováno v:
Gastric Cancer. 21:439-445
A combination of S-1 and cisplatin is recognized as one of the standard first-line chemotherapy regimens for patients with advanced gastric cancer. However, demographic analyses of pivotal phase III studies have showed that only a minority of treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f37146e88dcb6515ea5721c4080dbda
https://doi.org/10.1007/s10120-017-0753-2
https://doi.org/10.1007/s10120-017-0753-2
Autor:
Yuko Tsuboguchi, Haruko Daga, Yumi Yoshii, Kohei Akiyoshi, Shinya Tokunaga, Shunsuke Okazaki, Hitoshi Goto, Shinya Ueda, Kazuyoshi Fukai, Masataka Shimozono, Yuki Nakatani
Publikováno v:
Annals of Oncology. 30:vi124-vi125
Background Choroidal melanoma with metastasis is known to have a poor prognosis with no established standard therapy. Recently there are some case reports that combination therapy of IPI and NIVO is effective, but with high incidence of immune-relate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::438c595c403a5f10abb1b4c1d8aea197
https://doi.org/10.1093/annonc/mdz343.032
https://doi.org/10.1093/annonc/mdz343.032
Autor:
Kohei Akiyoshi, Yumi Yoshii, Shinya Tokunaga, Yuki Nakatani, Shinya Ueda, Yuko Tsuboguchi, Haruko Daga, Shunsuke Okazaki
Publikováno v:
Annals of Oncology. 30:vi139-vi140
Background Immuno-checkpoint inhibitors, nivolumab targeting programmed cell death 1 (PD-1) can result in significant benefit to gastric cancer. Some recent data about non-small cell lung cancer suggest anti-PD-1 therapy may enhance sensitivity to su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d936a978b6c57762c541041b72163d18
https://doi.org/10.1093/annonc/mdz343.102
https://doi.org/10.1093/annonc/mdz343.102
Publikováno v:
IABSE Symposium, Vancouver 2017: Engineering the Future.
Fatigue cracks of steel structural members applied by overload, repeated load occur. As a countermeasure, there are some repair methods of steel fatigue cracks such as a stiffening plate method, a weld repair method, a stop-hole method, and a mechani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d896ddf9bc9b10b50e4efd4f5b6660f
https://doi.org/10.2749/vancouver.2017.0663
https://doi.org/10.2749/vancouver.2017.0663
Autor:
Asuka Tsuya, Shunsuke Okazaki, Yuko Tsuboguchi, Shinya Ueda, Shinya Tokunaga, Kohei Akiyoshi, Yuki Nakatani, Haruko Daga, Yumi Yoshii
Publikováno v:
Annals of Oncology. 29:ix36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44f84ea804e35b68922271cfb68f9102
https://doi.org/10.1093/annonc/mdy431.025
https://doi.org/10.1093/annonc/mdy431.025